• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JIANG Siyu,MA Yanan,YANG Lan,LIU Huanhuan,LIANG Chan,WU Xiaoguang.The impact of Liraglutide on renal fibrosis in rats with diabetes type 2[J].Journal Of Pharmaceutical Research,2017,36(1):6-8[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4878times   Download 3648次 QR Code for this article
Scan with your phone!
利拉鲁肽对2型糖尿病大鼠肾脏纤维化影响的作用研究
江思瑜1,马亚楠1,杨岚2,刘欢欢1,梁婵1,吴晓光2
Font:Larger+|Default|Smaller-
(1.承德医学院基础医学院,河北 承德 067000;2.承德医学院基础研究所,河北 承德 067000)
摘要:
目的 探究利拉鲁肽在糖尿病致肾脏纤维化过程中的影响及作用机制。方法 随机选取大鼠20只,为正常组(NC组);40只经高脂高糖结合链脲佐菌素注射复制糖尿病大鼠模型,再随机分为糖尿病组(DM组)、利拉鲁肽组(LR组);利拉鲁肽皮下注射,0.15 mg·(kg·d)-1,NC组、DM组给予等体积的溶媒。给药8 周后检测24 h尿蛋白排泄(24 hUP)、尿素氮(BUN)、血清肌酐 (SCr)水平。光镜下观察大鼠肾脏病理。Toll样受体4由免疫组化法检测。ELISA检测转化生长因子-β1、结缔组织生长因子含量。结果 与正常组比较,利拉鲁肽组24 h尿蛋白排泄、尿素氮、血清肌酐水平升高(P<0.05),Toll样受体4表达增加(P<0.05),肾脏纤维化程度加深;与糖尿病组比较,利拉鲁肽组24 h尿蛋白排泄、尿素氮、血清肌酐水平下降(P<0.05),Toll样受体4表达减少(P<0.05),纤维化程度好转。结论 利拉鲁肽能够改善肾脏纤维化,其机制可能与抑制Toll样受体4通路有关。
关键词:  利拉鲁肽  Toll样受体4  转化因子-β1  结缔组织生长因子
DOI:10.13506/j.cnki.jpr.2017.01.002
基金项目:国家级大学生创新创业训练计划项目(No.201606)
The impact of Liraglutide on renal fibrosis in rats with diabetes type 2
JIANG Siyu1,MA Yanan1,YANG Lan2,LIU Huanhuan1,LIANG Chan1,WU Xiaoguang2
(1.Chengde Medical College of Basic Medical Sciences 2013,Chengde 067000,China;2.Institute of Basic Medical College,Chengde 067000,China)
Abstract:
Objective To explore the effect and mechanism of liraglutide in diabetes-induced renal fibrosis process.Methods 20 rats were randomly selected as the normal group (NC group);40 rats were randomly selected to bhild DM rat model by the way which injected with high-fat and high-sugar combined with streptozotocin to replicate,then the 40 rats were randomly divided into diabetic group(DM),liraglutide group(LR group);LR subcutaneous liraglutide group,0.15 mg·(kg·d)-1,NC group,DM group was given the same amount of solvent.Observeing the change of rat kidney tissue morphology.Immunohistochemical detection TLR4 protein molecule expression.Elisa method detected the levels of TGF-β1,CTGF.Results Compared with NC group ,the 24 hUP,BUN,SCr levels of LR group was increased(P<0.05),the TLR4expression of LR group was increased(P<0.05),renal fibrosis deepened;compared with DM group,LR group, the 24 hUP,BUN,SCr levels of LR group decreased(P<0.05),the TLR4 expression of LR group was increased(P<0.05),fibrosis improved.Conclusion Liraglutide can improve renal fibrosis, which may be related to inhibiting TLR4pathway.
Key words:  Liraglutide  TLR4  TGF-β1  CTGF
Today's Visits:443    Total Visits:2383124
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.